215 related articles for article (PubMed ID: 17268158)
1. Effects of low-dose milrinone on weaning from cardiopulmonary bypass and after in patients with mitral stenosis and pulmonary hypertension.
Oztekin I; Yazici S; Oztekin DS; Goksel O; Issever H; Canik S
Yakugaku Zasshi; 2007 Feb; 127(2):375-83. PubMed ID: 17268158
[TBL] [Abstract][Full Text] [Related]
2. Inhaled versus intravenous milrinone in mitral stenosis with pulmonary hypertension.
Patel J; Patel K; Garg P; Patel S
Asian Cardiovasc Thorac Ann; 2021 Mar; 29(3):170-178. PubMed ID: 33108898
[TBL] [Abstract][Full Text] [Related]
3. Dobutamine and Nitroglycerin Versus Milrinone for Perioperative Management of Pulmonary Hypertension in Mitral Valve Surgery. A Randomized Controlled Study.
Eskandr AM; Metwally AA; Abu Elkassem MS; Sadik SA; Elmiligy AE; Mourad M; Hussein L
J Cardiothorac Vasc Anesth; 2018 Dec; 32(6):2540-2546. PubMed ID: 29880427
[TBL] [Abstract][Full Text] [Related]
4. Comparison of inhaled and intravenous milrinone in patients with pulmonary hypertension undergoing mitral valve surgery.
Wang H; Gong M; Zhou B; Dai A
Adv Ther; 2009 Apr; 26(4):462-8. PubMed ID: 19381522
[TBL] [Abstract][Full Text] [Related]
5. Cardiopulmonary effects of enoximone or dobutamine and nitroglycerin on mitral valve regurgitation and pulmonary venous hypertension.
Hachenberg T; Möllhoff T; Holst D; Hammel D; Brüssel T
J Cardiothorac Vasc Anesth; 1997 Jun; 11(4):453-7. PubMed ID: 9187994
[TBL] [Abstract][Full Text] [Related]
6. A retrospective comparison of inhaled milrinone and iloprost in post-bypass pulmonary hypertension.
Theodoraki K; Thanopoulos A; Rellia P; Leontiadis E; Zarkalis D; Perreas K; Antoniou T
Heart Vessels; 2017 Dec; 32(12):1488-1497. PubMed ID: 28717881
[TBL] [Abstract][Full Text] [Related]
7. A placebo-controlled trial verifying the efficacy of milrinone in weaning high-risk patients from cardiopulmonary bypass.
Doolan LA; Jones EF; Kalman J; Buxton BF; Tonkin AM
J Cardiothorac Vasc Anesth; 1997 Feb; 11(1):37-41. PubMed ID: 9058218
[TBL] [Abstract][Full Text] [Related]
8. Inhaled iloprost to control pulmonary artery hypertension in patients undergoing mitral valve surgery: a prospective, randomized-controlled trial.
Rex S; Schaelte G; Metzelder S; Flier S; de Waal EE; Autschbach R; Rossaint R; Buhre W
Acta Anaesthesiol Scand; 2008 Jan; 52(1):65-72. PubMed ID: 17976224
[TBL] [Abstract][Full Text] [Related]
9. Comparison of two different loading doses of milrinone for weaning from cardiopulmonary bypass.
De Hert SG; Moens MM; Jorens PG; Delrue GL; DePaep RJ; Vermeyen KM
J Cardiothorac Vasc Anesth; 1995 Jun; 9(3):264-71. PubMed ID: 7669958
[TBL] [Abstract][Full Text] [Related]
10. Comparative Effect of Levosimendan and Milrinone in Cardiac Surgery Patients With Pulmonary Hypertension and Left Ventricular Dysfunction.
Mishra A; Kumar B; Dutta V; Arya VK; Mishra AK
J Cardiothorac Vasc Anesth; 2016 Jun; 30(3):639-46. PubMed ID: 27321790
[TBL] [Abstract][Full Text] [Related]
11. [The effect of milrinone administrated before weaning from cardiopulmonary bypass in adult cardiac surgery].
Hibino N; Tomino T; Satoh H; Hamawaki M; Imura M; Suzuki T; Inukai M
Kyobu Geka; 2000 Nov; 53(12):1019-23. PubMed ID: 11079307
[TBL] [Abstract][Full Text] [Related]
12. Preliminary experience with inhaled milrinone in cardiac surgery.
Lamarche Y; Perrault LP; Maltais S; Tétreault K; Lambert J; Denault AY
Eur J Cardiothorac Surg; 2007 Jun; 31(6):1081-7. PubMed ID: 17400468
[TBL] [Abstract][Full Text] [Related]
13. The effect of milrinone on metabolism after cardiopulmonary bypass.
Tatlis A; Papakonstantinou C; Toumbouras M; Gerolioliou K; Spanos P
J Cardiovasc Surg (Torino); 2008 Feb; 49(1):113-8. PubMed ID: 18212696
[TBL] [Abstract][Full Text] [Related]
14. Hemodynamic effects of milrinone during weaning from cardiopulmonary bypass: comparison of patients with a low and high prebypass cardiac index.
Yamada T; Takeda J; Katori N; Tsuzaki K; Ochiai R
J Cardiothorac Vasc Anesth; 2000 Aug; 14(4):367-73. PubMed ID: 10972598
[TBL] [Abstract][Full Text] [Related]
15. [Alterations in pulmonary artery pressure following mitral valve replacement].
Lafçı G; Diken AI; Gedik HS; Korkmaz K; Özcan F; Taşoğlu İ; Altıntaş G; Çağlı K
Turk Kardiyol Dern Ars; 2012 Apr; 40(3):235-41. PubMed ID: 22864319
[TBL] [Abstract][Full Text] [Related]
16. Preliminary experience with combined inhaled milrinone and prostacyclin in cardiac surgical patients with pulmonary hypertension.
Laflamme M; Perrault LP; Carrier M; Elmi-Sarabi M; Fortier A; Denault AY
J Cardiothorac Vasc Anesth; 2015 Feb; 29(1):38-45. PubMed ID: 25440627
[TBL] [Abstract][Full Text] [Related]
17. A multicenter, randomized, blind comparison of amrinone with milrinone after elective cardiac surgery.
Rathmell JP; Prielipp RC; Butterworth JF; Williams E; Villamaria F; Testa L; Viscomi C; Ittleman FP; Baisden CE; Royster RL
Anesth Analg; 1998 Apr; 86(4):683-90. PubMed ID: 9539583
[TBL] [Abstract][Full Text] [Related]
18. Effects of concomitant usage of milrinone and catecholamine for weaning from cardiopulmonary bypass.
Orime Y; Shiono M; Hata H; Yagi S; Tsukamoto S; Kimura S; Ohmiya S; Sezai A; Yamada H; Obana M; Sezai Y
Jpn J Thorac Cardiovasc Surg; 1998 Sep; 46(9):803-9. PubMed ID: 9796277
[TBL] [Abstract][Full Text] [Related]
19. Amrinone versus dobutamine in cardiac surgical patients with severe pulmonary hypertension after cardiopulmonary bypass: a prospective, randomized double-blinded trial.
Jenkins IR; Dolman J; O'Connor JP; Ansley DM
Anaesth Intensive Care; 1997 Jun; 25(3):245-9. PubMed ID: 9209604
[TBL] [Abstract][Full Text] [Related]
20. Treatment of pulmonary hypertension in patients undergoing cardiac surgery with cardiopulmonary bypass: a randomized, prospective, double-blind study.
Fattouch K; Sbraga F; Sampognaro R; Bianco G; Gucciardo M; Lavalle C; Vizza CD; Fedele F; Ruvolo G
J Cardiovasc Med (Hagerstown); 2006 Feb; 7(2):119-23. PubMed ID: 16645371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
